Skip Main Navigation
Page Content
This event has ended

Save This Event

Event Saved

Clinical use of Guardant 360

HCA Healthcare UK Laboratories

Wednesday, 29 November 2017 from 18:00 to 19:30 (GMT)

Clinical use of Guardant 360

Ticket Information

Type End Quantity
Clinical Use of Guardant 360 Ended Free  

Share Clinical use of Guardant 360

Event Details

HCA’s Cancer Service line has worked together with Guardant Health to make the Guardant 360 assay genetic test available. 

 This blood-based genetic test is used by oncologists to match patients with advanced cancer to targeted therapy or clinical trials, without requiring an invasive tissue biopsy. It can detect 73 genes associated with cancer and can detect single nucleotide variants, insertion and deletion events, copy number amplifications, and fusions. 

A member of Guardant Health will be discussing the global data about the Guardant 360 Liquid Biopsy test, its use and indications. Case examples will be presented by Dr Tobias Arkenau.

6:00pm – 6.30pm Arrival and registration (Light dinner and drinks)

6.30pm – 6.50pm Presentation of G360: Indications, validations, guidelines and coverage

Iris Faull, Director of Business Development & Medical Affairs – Guardant Health 

6.50pm – 7.10pm Case studies
Dr Tobias Arkenau, Consultant Medical Oncologist – Sarah Cannon Research Institute 

7.10pm – 7.20pm Q&A 


To book your place, please click on the 'Register' button

Do you have questions about Clinical use of Guardant 360? Contact HCA Healthcare UK Laboratories

When & Where

Leaders in Oncology Care Board Room
95 Harley Street
W1G 6AF London
United Kingdom

Wednesday, 29 November 2017 from 18:00 to 19:30 (GMT)

  Add to my calendar

Interested in hosting your own event?

Join millions of people on Eventbrite.

Please log in or sign up

In order to purchase these tickets in installments, you'll need an Eventbrite account. Log in or sign up for a free account to continue.